FIELD: medicine.
SUBSTANCE: invention can be used to treat a wide range of skin lesions infected: ulcers, eczema, wound infections, bitten wounds, pressure sores, psoriasis, herpes, leprosy. The following active ingredients per 100 g of the base are included in the composition of the ointment for skin infections treatment: rifampicin and doxycycline hyclate antibiotics in equal proportions 1-3 g each, human recombinant interferon alpha-2b 250000 - 500000 ME, the vaseline base is the rest.
EFFECT: effectively overcomes the factors of pathogenic microbes resistance and expands the spectrum of action on all types of skin infectious lesions.
2 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR SKIN INFECTIONS TREATMENT | 2017 |
|
RU2639085C1 |
METHOD FOR TREATING ACUTE HEPRETIC STOMATITIS IN CHILDREN | 2011 |
|
RU2444372C1 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
MEDICINE WITH IMMUNE MODIFYING, ANTIVIRUS, ANTIBACTERIAL ANTIOXIDISING, MEMBRANE STABILISING, CARTILAGE AND CONNECTIVE TISSUE GROWTH STIMULATING EFFECT | 2007 |
|
RU2349339C1 |
COMPLEX ANTIVIRAL MEDICATION FOR EXTERNAL APPLICATION IN TREATMENT OF HERPES VIRUS INFECTIONS | 2010 |
|
RU2438697C1 |
ANALGETIC AND ANTI-ITCHING AGENT | 1997 |
|
RU2147440C1 |
IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
AGENT POSSESSING IMMUNOMODULATORY AND ANTIVIRAL ACTIVITY | 2015 |
|
RU2592201C1 |
Authors
Dates
2017-11-29—Published
2017-01-31—Filed